• Leave Your Message
    Products Categories
    Featured Products

    CAS No.2346620-55-9 Pharmaceutical Intermediates

    Product name

    Molnupiravir Intermediates

    CAS No.

    2346620-55-9

    Other name

    ((3AR,4R,6R,6AR)-6-(4-(HYDROXYAMINO)-2-OXOPYRIMIDIN-1(2H)-YL)-2,2-DIMETHYLTETRAHYDROFURO[3,4-D][1,3]DIOXOL-4-YL)METHYL ISOBUTYRATE

    EINECS  

    /

    Formula

    C16H23N3O7

    Molecular Weight

    369.37

    Appearance

    White powder

    Purity

    ≥98%

    Type

    Pharmaceutical Intermediates

    - High Purity: Our Molnupiravir intermediates have exceptional purity, ensuring optimal performance in pharmaceutical applications.

    - Integrating production and trading: As a factory integrating production and trading, we provide competitive prices and reliable supply chain.

    - Advanced Manufacturing: Utilizing state-of-the-art technologies, we ensure consistent quality and efficiency of our production processes.

    - Regulatory Compliance: Our products meet strict regulatory standards and are suitable for a variety of pharmaceutical applications.

    - Expertise in Pharmaceutical Intermediates: With many years of experience in the industry, we provide customized solutions to meet specific customer needs.

      Product details

      2346620-55-9
      02

      overview

      Molnupiravir intermediates are important building blocks for the synthesis of Molnupiravir, an antiviral drug that has attracted much attention for its efficacy against viral infections, especially COVID-19. Our intermediates are designed to facilitate efficient production of this critical drug, ensuring that pharmaceutical companies can meet the growing demand for effective antiviral therapies.

      2346620-55-9 (2)
      02

      Physical and Chemical Properties

      - Molecular Structure: The intermediates have a well-defined molecular structure, which is crucial for the synthesis of the final product. This structural integrity ensures that the intermediates can be easily converted into Molnupiravir in high yield.
      - Solubility: These intermediates are designed to have optimal solubility in a variety of solvents, which is critical for the synthetic process. This property enables easier handling and processing during manufacturing.
      - Stability: Our intermediates exhibit excellent stability under a wide range of conditions, ensuring they maintain their efficacy throughout the manufacturing process. This stability is critical for pharmaceutical applications where consistency is crucial.
      - Purity Level: We guarantee high purity levels, typically over 98%, which is critical for pharmaceutical applications. High purity minimizes the risk of impurities that could affect the safety and efficacy of the final product.

      Advantages 

           1. Increase efficiency: By using our high-quality intermediates, pharmaceutical manufacturers can streamline their production processes and reduce the time and costs associated with synthesis.
           2. Quality Assurance: Our stringent quality control measures ensure that every batch of intermediates meets the highest standards, giving our customers peace of mind.
           3. Customized Solutions: We understand that each customer has unique needs. Our team of experts can provide customized solutions, including custom intermediates to meet specific production requirements.
           4. Sustainable Practices: We are committed to sustainable manufacturing practices, ensuring our production processes maintain high quality while minimizing the impact on the environment.
           5. Global Influence: As an integrated production and trading factory, we have established a strong distribution network to serve global customers efficiently.

       Application

      Monupiravir intermediates play a vital role in the pharmaceutical industry, especially in the development of antiviral drugs. Its applications include:

      - Synthesis of Antiviral Drugs: These intermediates are primarily used in the synthesis of Molnupiravir, a drug recognized for its potential in treating viral infections including COVID-19.
      - Research and Development: Pharmaceutical companies use our intermediates for R&D to explore new formulations and therapeutic applications, contributing to the advancement of antiviral therapies.
      - Commercial Manufacturing: As the demand for effective antiviral drugs continues to increase, our intermediates support large-scale commercial manufacturing, enabling manufacturers to efficiently meet market demand.

      In summary

           In conclusion, our Molnupiravir intermediates are an essential component for pharmaceutical companies involved in the production of antiviral drugs. With high purity, excellent physical and chemical properties, and a commitment to quality and sustainability, we are committed to supporting the pharmaceutical industry in the development of effective treatments for viral infections. Partner with us to ensure that your production processes are efficient, reliable, and meet the highest industry standards.